Biocad ships Herceptin biosimilar to Sri Lanka
Biocad has begun supplying its biosimilar version of Roche’s Herceptin (trastuzumab) to breast cancer patients in Sri Lanka.
Biocad has begun supplying its biosimilar version of Roche’s Herceptin (trastuzumab) to breast cancer patients in Sri Lanka.
Bristol-Myers Squibb has announced plans to set up a biomanufacturing process laboratory in collaboration with Ireland's National Institute of Bioprocessing Research and Training (NIBRT).
Biosimilar acceptance among physicians has doubled to 80% since 2013, according to a survey presented at by copycat biologic distributor Celltrion Healthcare.
As Turkey becomes one of the world’s fastest growing economies, GE Healthcare launches collaborative research scheme to support Turkish biopharmaceutical industry.
WIRB-Copernicus Group (WCG) has assembled a team of experts to advise the company as it advances its gene therapy research.